NCT06481956 2024-07-01T-DM1 Combined With CDK4/6 Inhibitor RibociclibZhejiang Cancer HospitalPhase 2 Enrolling by invitation40 enrolled
NCT04903652 2022-04-07Pyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast CancerTianjin Medical University Cancer Institute and HospitalPhase 2 Completed30 enrolled